Keratosis
MONDO:0006566A skin disorder consisting of hypertrophy of the stratum corneum of the skin.
Also known as: keratoderma
30 clinical trials for this condition and its sub-types, 5 tagged with Keratosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Keratosis
-
Palmoplantar keratosis 4 trials · 16 incl. sub-types
2 sub-types
- Hereditary palmoplantar keratoderma 0 trials · 13 incl. sub-types Sub-types →
- Aquagenic palmoplantar keratoderma 1 trial
-
Seborrheic keratosis 6 trials
5 sub-types
- Eyelid seborrheic keratosis 0 trials
- Inflamed seborrheic keratosis 0 trials
- Inverted follicular keratosis 0 trials Sub-types →
- Melanoacanthoma 0 trials
- Vulvar seborrheic keratosis 0 trials Sub-types →
-
Cholesteatoma 1 trial · 3 incl. sub-types
3 sub-types
- Cholesteatoma of middle ear 2 trials Sub-types →
- Cholesteatoma of external ear 0 trials
- Maxillary sinus cholesteatoma 0 trials
-
Acrokeratosis verruciformis 1 trial
-
Acquired keratosis 0 trials
-
2 sub-types
-
Porokeratosis 0 trials
4 sub-types
- Disseminated superficial actinic porokeratosis 0 trials Sub-types →
- Linear porokeratosis 0 trials
- Porokeratosis of Mibelli 0 trials Sub-types →
- Porokeratosis plantaris palmaris et disseminata 0 trials
-
Trichostasis spinulosa 0 trials
Most studied deeper sub-types
-
Could a psoriasis drug help thickened hands and feet?
Disease control OngoingThis study tests a daily cream called tapinarof, already used for psoriasis, in 6 adults with palmoplantar keratoderma — a condition that causes painful thickening of skin on the palms and soles. Researchers want to see if the cream can clear or improve the skin and check for sid…
Phase 2 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for ALS patients: experimental drug CNM-Au8 now available through expanded access
Disease control Expanded access (paused)This program provides early access to an experimental drug called CNM-Au8 for people with amyotrophic lateral sclerosis (ALS), a progressive nerve disease. Participants must be 18 or older and have a confirmed ALS diagnosis. The goal is to offer treatment to those who cannot join…
Sponsor: Clene Nanomedicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Desperate patient gets experimental stem cells for rare nerve disease
Disease control Expanded access (ended)This study provides an experimental stem cell treatment (HB-adMSCs) to an 83-year-old man with Primary Lateral Sclerosis, a rare nerve disease that causes progressive muscle weakness. The patient's own banked stem cells are used, aiming to slow the disease. This is a single-patie…
Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Bioactive glass could ease ear surgery After-Effects
Symptom relief By invitation onlyThis study tests whether using bioactive glass granules during a second ear surgery can improve quality of life for people with ongoing problems like discharge, dizziness, or trouble using hearing aids. Fifty adults who had prior ear surgery will receive the procedure and be foll…
Sponsor: Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC